Neuphoria Therapeutics Cash Flow Statement (2021-2026) | NEUP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2021 Dec2021 Jun2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -5.47M-4.55M-2.78M-0.87M-0.80M-1.94M11.26M-9.35M-9.91M1.86M-0.51M
Share-based Compensation (Quarter) 0.13M0.70M0.10M0.11M0.03M0.10M0.10M0.10M0.11M0.10M0.10M
Gains from Sales and Divestitures (Quarter) 0.03M0.01M
Gains from Investment Securities (Quarter) 56.63M2.34M-0.04M0.05M-0.10M0.14M0.09M0.05M0.05M3.49M0.05M0.14M0.12M
Non-cash Items (Quarter) 0.10M0.10M0.10M0.10M0.06M0.45M0.40M0.08M
Cash from Operations (Quarter) -4.43M-3.95M-3.30M-3.01M-4.43M-3.36M11.45M-3.59M-3.79M-6.44M-3.40M
Depreciation, Depletion & Amortization
Amortization (Quarter) 7.66M7.14M
Depreciation & Amortization (CF) (Quarter) 0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M
Change in Working Capital
Change in Receivables (Quarter) 0.02M-0.33M-0.01M0.02M-0.01M-0.08M-0.01M-0.01M-0.01M1.11M0.50M
Change in Account Payables (Quarter) 0.88M-0.87M-0.87M1.66M-0.92M0.20M-0.79M0.58M0.22M-0.85M0.11M
Change in Accured Expenses (Quarter) -0.70M0.96M-0.47M0.50M-0.37M-0.79M0.38M2.27M0.72M-1.60M-1.18M
Other Working Capital Changes (Quarter) -0.03M-0.01M-0.12M0.15M551.00-0.07M-0.13M0.65M-0.03M-0.68M-0.01M
Financing Activities
Other financing activities (Quarter) 0.50M0.30M0.23M0.10M0.50M
Cash from Financing Activities (Quarter) 0.61M5.63M1.75M7.12M-0.23M-0.11M1.16M0.70M3.25M14.66M
Additional items
Exchange Rate Effect (Quarter) -0.15M0.34M-0.19M0.07M0.14M-0.28M0.08M0.05M-0.02M0.30M0.53M
Change in Cash (Quarter) -3.82M1.87M-1.73M4.18M-4.52M-3.75M12.70M-2.83M-0.56M8.52M-2.81M
Free Cash Flow (Quarter) -4.43M-3.95M-3.30M-3.01M-4.43M-3.36M11.45M-3.59M-3.79M-6.44M-3.40M
Net Cash Flow (Quarter) -3.82M1.68M-1.55M4.11M-4.66M-3.47M12.62M-2.88M-0.54M8.23M-3.40M